Mutahi; Mwangi W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mutahi; Mwangi W..The latest application filed is for "heteroatom-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists".

Company Profile

0.12.11

Mutahi; Mwangi W. - Nyeri N/A KE
Mutahi; Mwangi W. - Fords NJ
Mutahi; Mwangi W. - Orange NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Functionally selective alpha2C adrenoreceptor agonists Grant 8,383,818 - Zheng , et al. February 26, 2	2013-02-26
Substituted aniline derivatives useful as histamine H3 antagonists Grant 7,879,880 - Solomon , et al. February 1, 2	2011-02-01
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,846,946 - Aslanian , et al. December 7, 2	2010-12-07
Phenoxypiperidines and analogs thereof useful as histamine H.sub.3 antagonists Grant 7,638,531 - Mutahi , et al. December 29, 2	2009-12-29
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,635,705 - Aslanian , et al. December 22, 2	2009-12-22
Heteroatom-linked Substituted Piperidines And Derivatives Thereof Useful As Histamine H3 Antagonists App 20090286830 - Aslanian; Robert G. ; et al.	2009-11-19
Carbon-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,408,066 - Aslanian , et al. August 5, 2	2008-08-05
Novel Non-imidazole Compounds App 20080119487 - Aslanian; Robert G. ; et al.	2008-05-22
Non-imidazole compounds Grant 7,300,941 - Aslanian , et al. November 27, 2	2007-11-27
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists App 20070167435 - Mutahi; Mwangi W. ; et al.	2007-07-19
Substituted aniline derivatives useful as histamine H3 antagonists App 20070142394 - Solomon; Daniel M. ; et al.	2007-06-21
Benzimidazolone histamine H.sub.3 antagonists Grant 7,220,735 - Ting , et al. May 22, 2	2007-05-22
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists App 20070015807 - Aslanian; Robert G. ; et al.	2007-01-18
Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists App 20070010513 - Aslanian; Robert G. ; et al.	2007-01-11
Benzimidazole derivatives useful as histamine H3 antagonists Grant 7,105,505 - Zeng , et al. September 12, 2	2006-09-12
Indole derivatives useful as histamine H3 antagonists Grant 6,951,871 - Aslanian , et al. October 4, 2	2005-10-04
Novel non-imidazole compounds App 20040097513 - Aslanian, Robert G. ; et al.	2004-05-20
Benzimidazole derivatives useful as histamine H3 antagonists App 20040097483 - Zeng, Qingbei ; et al.	2004-05-20
Non-imidazole compounds Grant 6,720,328 - Aslanian , et al. April 13, 2	2004-04-13
Benzimidazolone histamine H3 antagonists App 20040048843 - Ting, Pauline C. ; et al.	2004-03-11
Indole derivatives useful as histamine H3 antagonists App 20040019099 - Aslanian, Robert G. ; et al.	2004-01-29
Novel non-imidazole compounds App 20030045519 - Aslanian, Robert G. ; et al.	2003-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.